134 related articles for article (PubMed ID: 34412920)
1. Booster immunization improves the generation of T follicular helper (Tfh) cells specific to hepatitis B surface antigen (HBsAg) after prenatal HBsAg exposure.
Wang R; Chen K; Wang Y; Liu C; Wu Z; Wang D; Qu C
Vaccine; 2021 Sep; 39(39):5571-5579. PubMed ID: 34412920
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated Response of Follicular Helper T Cells to Hepatitis B Surface Antigen Promotes HBV Persistence in Mice and Associates With Outcomes of Patients.
Wang X; Dong Q; Li Q; Li Y; Zhao D; Sun J; Fu J; Meng F; Lin H; Luan J; Liu B; Wang M; Wang FS; He F; Tang L
Gastroenterology; 2018 Jun; 154(8):2222-2236. PubMed ID: 29544722
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study.
Chang YC; Wang JH; Chen YS; Lin JS; Cheng CF; Chu CH
BMC Public Health; 2014 Sep; 14():991. PubMed ID: 25248369
[TBL] [Abstract][Full Text] [Related]
4. Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination.
Zhu CL; Liu P; Chen T; Ni Z; Lu LL; Huang F; Lu J; Sun Z; Qu C
Vaccine; 2011 Oct; 29(44):7835-41. PubMed ID: 21816197
[TBL] [Abstract][Full Text] [Related]
5. Diverse immune responses to HBV surface epitope variants after vaccine booster in adolescents immunized in infancy.
Lai MW; Liang KH; Yeh CT
Clin Microbiol Infect; 2019 Sep; 25(9):1140-1146. PubMed ID: 30771531
[TBL] [Abstract][Full Text] [Related]
6. Adolescent booster with hepatitis B virus vaccines decreases HBV infection in high-risk adults.
Wang Y; Chen T; Lu LL; Wang M; Wang D; Yao H; Fan C; Qi J; Zhang Y; Qu C
Vaccine; 2017 Feb; 35(7):1064-1070. PubMed ID: 28069363
[TBL] [Abstract][Full Text] [Related]
7. Immune correlates of hepatitis B surface antigen spontaneous seroconversion in hepatitis B e antigen negative chronic hepatitis B patients.
Vyas AK; Sharma BC; Sarin SK; Trehanpati N
Liver Int; 2018 Jan; 38(1):38-49. PubMed ID: 28500636
[TBL] [Abstract][Full Text] [Related]
8. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
Zeng Z; Kong X; Li F; Wei H; Sun R; Tian Z
J Immunol; 2013 Oct; 191(8):4184-93. PubMed ID: 24048897
[TBL] [Abstract][Full Text] [Related]
9. The hepatitis B vaccine protects re-exposed health care workers, but does not provide sterilizing immunity.
Werner JM; Abdalla A; Gara N; Ghany MG; Rehermann B
Gastroenterology; 2013 Nov; 145(5):1026-34. PubMed ID: 23916846
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of vaccinating infants with a 5 µg recombinant yeast-derived hepatitis B vaccine and the need for a booster dose in China.
Miao N; Zheng H; Sun X; Zhang G; Wang F
Sci Rep; 2020 Oct; 10(1):18155. PubMed ID: 33097788
[TBL] [Abstract][Full Text] [Related]
11. A booster hepatitis B vaccine for children with maternal HBsAg positivity before 2 years of age could effectively prevent vaccine breakthrough infections.
Song Y; Zhang X; Liu M; Zhai X; Liu J; Li Y; Li L; Xiao Y; Duan Z; Jiang J; Ding F; Zhu L; Jiang J; Zou H; Zhuang H; Wang J; Li J
BMC Infect Dis; 2022 Nov; 22(1):863. PubMed ID: 36401190
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab.
Moses J; Alkhouri N; Shannon A; Raig K; Lopez R; Danziger-Isakov L; Feldstein AE; Zein NN; Wyllie R; Carter-Kent C
Am J Gastroenterol; 2012 Jan; 107(1):133-8. PubMed ID: 21876562
[TBL] [Abstract][Full Text] [Related]
13. Activation of CD4 T cells during prime immunization determines the success of a therapeutic hepatitis B vaccine in HBV-carrier mouse models.
Su J; Brunner L; Ates Oz E; Sacherl J; Frank G; Kerth HA; Thiele F; Wiegand M; Mogler C; Aguilar JC; Knolle PA; Collin N; Kosinska AD; Protzer U
J Hepatol; 2023 Apr; 78(4):717-730. PubMed ID: 36634821
[TBL] [Abstract][Full Text] [Related]
14. Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan.
Su FH; Bai CH; Chu FY; Lin YS; Su CT; Yeh CC
Vaccine; 2012 Jun; 30(27):4034-9. PubMed ID: 22531558
[TBL] [Abstract][Full Text] [Related]
15. IL-33 Enhances Humoral Immunity Against Chronic HBV Infection Through Activating CD4(+)CXCR5(+) TFH Cells.
Zhao PW; Shi X; Li C; Ayana DA; Niu JQ; Feng JY; Wang J; Jiang YF
J Interferon Cytokine Res; 2015 Jun; 35(6):454-63. PubMed ID: 25714983
[TBL] [Abstract][Full Text] [Related]
16. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
[TBL] [Abstract][Full Text] [Related]
17. Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China.
Wang ZZ; Gao YH; Lu W; Jin CD; Zeng Y; Yan L; Ding F; Li T; Liu XE; Zhuang H
Hum Vaccin Immunother; 2017 Apr; 13(4):909-915. PubMed ID: 27874311
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of hepatitis B vaccine booster in children born to HBsAg-positive mothers in rural China.
Wang Y; Shi JF; Wang L; Yan Y; Yao H; Dai M; Chen T; Qu C
Int J Infect Dis; 2019 Jan; 78():130-139. PubMed ID: 30466898
[TBL] [Abstract][Full Text] [Related]
19. Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China.
Wang F; Zhang G; Zheng H; Miao N; Shen L; Wang F; Dong P; Du F; Chen C; Zhang X; Cui F
Vaccine; 2017 Jul; 35(33):4229-4235. PubMed ID: 28651839
[TBL] [Abstract][Full Text] [Related]
20. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
